| 2024-05-14 | Entrada Therapeutics, Inc. TRDA | director | 25,000 0.0761% | $14.59 | $364,673 | +8.82% | ||
| 2024-05-09 | Entrada Therapeutics, Inc. TRDA | director | 2,200 0.0065% | $14.25 | $31,341 | +6.69% | ||
| 2024-05-08 | Entrada Therapeutics, Inc. TRDA | director | 2,276 0.0068% | $14.04 | $31,965 | +9% | ||
| 2024-04-08 | Entrada Therapeutics, Inc. TRDA | director | 2,600 0.0078% | $13.57 | $35,290 | +7.73% | ||
| 2024-03-28 | Entrada Therapeutics, Inc. TRDA | director | 1,512 0.0044% | $13.75 | $20,794 | +0.28% | ||
| 2024-03-26 | Entrada Therapeutics, Inc. TRDA | director | 2,750 0.0082% | $13.64 | $37,509 | +3.27% | ||
| 2024-03-25 | Entrada Therapeutics, Inc. TRDA | director | 3,180 0.0095% | $13.36 | $42,472 | +6.3% | ||
| 2024-03-22 | Entrada Therapeutics, Inc. TRDA | director | 3,118 0.0094% | $13.76 | $42,901 | +3.54% | ||
| 2024-03-21 | Entrada Therapeutics, Inc. TRDA | director | 704 0.0021% | $13.24 | $9,318 | +4.65% | ||
| 2024-03-20 | Entrada Therapeutics, Inc. TRDA | director | 1,128 0.0032% | $12.66 | $14,281 | +5.69% | ||
| 2024-03-19 | Entrada Therapeutics, Inc. TRDA | director | 900 0.0027% | $12.66 | $11,397 | +10.63% | ||
| 2012-11-05 | Sale | Merck & Co., Inc. MRK | Exe V-P & Pres, MRL | 840,000 0.0277% | $45.50 | $38.22M | +4.02% |